A case report on ofloxacin-induced Stevens–Johnson syndrome: Scorten-based approach

Authors

  • Afina T
  • C Mohammed Fasil
  • Kannan Rajendran
  • Masthan Marecar
  • Ashwath Ravichandran
  • MC Merlin Joan
  • Shivapriya Ravichandran

DOI:

https://doi.org/10.32677/ijcr.v9i1.3708

Keywords:

Ofloxacin, Stevens-johnson syndrome, Toxic epidermal necrolysis, Pharmacovigilance

Abstract

Stevens–Johnson syndrome (SJS) is a rare immune-mediated severe cutaneous adverse reaction with an incidence rate of 0.05–2 persons/ million population/month. Drugs are the most commonly implicated in 95% of cases. In our report, a 52-year-old male patient presented with chief complaints of skin rashes over the body and was having a history of using a tab. ofloxacin for gastroenteritis. The severity of SJS was assessed using SCORTEN (=1). The drug can be considered as a probable/likely cause of adverse drug reaction as per causality assessment of the suspected adverse drug reactions. Early diagnosis helps the clinician to elude secondary infection and subsequent complications. It highlights the mandatory reporting of the offending drug and the necessity of pharmacovigilance in different countries.

Downloads

Download data is not yet available.

Downloads

Published

2024-01-31

Issue

Section

Case Report

How to Cite

A case report on ofloxacin-induced Stevens–Johnson syndrome: Scorten-based approach. (2024). Indian Journal of Case Reports, 9(1), 29-31. https://doi.org/10.32677/ijcr.v9i1.3708

Most read articles by the same author(s)

<< < 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 > >>